Detailed answers about PHARMACENTRIC LIMITED, including incorporation, status, business activity, and accounts information.
When was PHARMACENTRIC LIMITED founded?
PHARMACENTRIC LIMITED was officially incorporated on 12 October 2006 and is registered under company number 05964690. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is PHARMACENTRIC LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of PHARMACENTRIC LIMITED?
PHARMACENTRIC LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does PHARMACENTRIC LIMITED do?
PHARMACENTRIC LIMITED operates in the following sector: 47730 - Dispensing chemist in specialised stores. This provides insight into the company's primary business activity and industry focus.
What is PHARMACENTRIC LIMITED's registered address?
The registered office address of PHARMACENTRIC LIMITED is 64 HIGH STREET, ELTHORNE GATE, PINNER, MIDDLESEX, ENGLAND, HA5 5QA. This is the official address filed with Companies House for legal and statutory correspondence.
Is PHARMACENTRIC LIMITED financially stable?
The most recent accounts for PHARMACENTRIC LIMITED were made up to 31 October 2024, filed as TOTAL EXEMPTION FULL. Next accounts are due by 31 July 2026.
Does PHARMACENTRIC LIMITED have any charges or mortgages?
PHARMACENTRIC LIMITED has 3 registered charges, of which 0 are outstanding, 3 satisfied, and 0 part satisfied. Charges are typically registered when a company uses its assets as security for borrowing.